title: Targeted therapy: Leveraging ADCC to enhance anti-HER2 therapy.
authors.forename: David
authors.initials: D
authors.lastname: Killock
mesh_terms: D000911:Antibodies, Monoclonal; D000920:Antibody-Dependent Cell Cytotoxicity; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab